ExoRehab X
$49.00
99 in stock
ExoRehab X: Home Gym Tailored for Neuro-Recovery
- Limited Availability: Only 300 custom-built devices will be available in 2022
- 2022 Pre-orders end August 31
- Shipments will be processed by September 15th and arrive within 6-8 weeks. Pre-orders will get priority in the delivery que.
ExoRehab X costs $3950. *Up to a 36-month financing option will be available for qualified individuals. The subscription for online training with other users, advanced personalization, and performance evaluation features is $29.99/month.
Pre-Order Details
- Pre-order is limited to 100 devices
- Deposit is fully refundable no questions asked
- Get prioritized delivery
- Enjoy $299 early-bird discount + free shipping and installation
- Be part of shaping the future of neuro-recovery with your direct feedback to the R&D team
Complete Upper Extremity Training
Isolate and work on shoulder, elbow, forearm and wrist movements
Highly Ergonomic and Adjustable Structure
The chair and the exoskeleton are tailored for your body measurements and easy to adjust
Objective Performance Data
Onboard sensors capture every increment of improvement
Not Just an Exercise Equipment
A portal for connecting with fellow stroke survivors online
Gamified Training at the Comfort of Your Home
Training regimen that progressively pushes you forward
ExoRehab X tailors the training according to your movement capability and challenges you gradually based on your performance on every training session.
Witness Your Strength
Measure results in days, not months
Measure Your Performance
ExoRehab senses even the slightest improvement on your movement capability and keeps you motivated by reporting your progress daily using understandable metrics.
Move Forward Together
Train together with fellow stroke survivors online
You are not alone on your journey to recovery. With ExoRehab X, train with others online and push each other forward.
Clinically Proven Results
Chronic stage stroke survivors achieved on average 2.96 times higher improvement on the capability of carrying out activities of daily living compared to the control group which received conventional therapy (measured with Fugl-Meyer Assessment – FMA)